Supramolecular nanotherapeutics enable metabolic reprogramming of <scp>tumor‐associated</scp> macrophages to inhibit tumor growth-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Supramolecular nanotherapeutics enable metabolic reprogramming of tumor‐associated macrophages to inhibit tumor growth

Published:2022-04-07 Issue:8 Volume:110 Page:1448-1459
ISSN:1549-3296
Container-title:Journal of Biomedical Materials Research Part A
language:en
Short-container-title:J Biomedical Materials Res

Author:

Ramesh Anujan¹^ORCID,Malik Vaishali²,Brouillard Anthony³,Kulkarni Ashish¹²³^ORCID

Affiliation:

1. Department of Biomedical Engineering University of Massachusetts Amherst Massachusetts USA

2. Department of Molecular and Cellular Biology University of Massachusetts Amherst Massachusetts USA

3. Department of Chemical Engineering University of Massachusetts Amherst Massachusetts USA

Funder

U.S. Department of Defense

Publisher

Wiley

Subject

Metals and Alloys,Biomedical Engineering,Biomaterials,Ceramics and Composites

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbm.a.37391

Reference38 articles.

1. Tissue-Resident Macrophages Are Locally Programmed for Silent Clearance of Apoptotic Cells

2. Tissue-resident macrophages

3. Targeting macrophages: a novel avenue for cancer drug discovery

4. Myeloid Colony-Stimulating Factors as Regulators of Macrophage Polarization

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapy;Acta Pharmaceutica Sinica B;2024-07

2. Cancer energy reprogramming and the immune responses;Cytokine;2024-05

3. Advanced nanomaterials for enhanced immunotherapy via metabolic regulation;Coordination Chemistry Reviews;2024-02

4. Nano-medicine therapy reprogramming metabolic network of tumour microenvironment: new opportunity for cancer therapies;Journal of Drug Targeting;2024-02

5. Fatty acid metabolism of immune cells: a new target of tumour immunotherapy;Cell Death Discovery;2024-01-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3